Da en stigning i koncentrationer af HMG - CoA reduktasehæmmere kan forårsage myopati, derunder rhabdomyolyse, anbefales kombination af disse produkter med Kaletra ikke.
Since increased concentrations of HMG-CoA reductase inhibitors may cause myopathy, including rhabdomyolysis, the combination of these medicinal products with Kaletra is not recommended.